Toll-like receptors and the eye

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 5, 2005, Pages 451-458

  Micera, Alessandra ^a,b   Stampachiacchiere, Barbara ^b   Aronni, Silvia ^a   Dos Santos, Myrna Serapiao ^a,c   Lambiase, Alessandro ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allergy; Corneal keratitis; Infections; Ocular surface; Toll like receptors; Vernal keratoconjunctivitis

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ALLERGY; EYE; EYE INFLAMMATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; KERATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

EID: 25144508781     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000182537.55650.99     Document Type: Review

References (64)

1. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:89-97.
2. Akira S, Kiyoshi T, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-680.
3. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9.
4. Beutler B. Interferences, questions and possibility of toll-like receptor signalling. Nature 2004; 430:257-263. This review discusses new concepts regarding the relationship between TLRs and immune/adaptive responses, during the development of chronic inflammatory responses in animals as well as in allergic disorders. The role of TLRs in the modulation of local inflammatory responses is also discussed.
5. Hemmi H, Takenchi O, Kawci T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-745.
6. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
7. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol 2003; 74:179-185.
8. Said NA, Shoeir AT, Panjwani N, et al. Local and systemic humoral immune response during acute and chronic Acanthamoeba keratitis in rabbits. Curr Eye Res 2004; 29:429-439.
9. Homer AA, Redecke V, Raz E. Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol 2004; 4:555-561.
10. Elson CO, Cong Y. Understanding immune-microbial homeostasis in intestine, Immunol Res 2002; 26:87-94.
11. Xu Y, Tao X, Shen B, et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000; 408:111-115.
12. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-14.
13. Imler JL, Zheng L. Biology of Toll receptors: lessons from insects and mammals. J Leukoc Biol 2004; 75:18-26.
14. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-376.
15. Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Intervent 2003; 3:466-477.
16. Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001; 14:499-502.
17. Sen GC, Sarkar SN. Transcriptional signalling by double-stranded RNA: role of TLR3. Cytokine Growth Fact Rev 2005; 16:1-14.
18. Sarkar SN, Peters KL, Elco CP, et al. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signalling. Nat Struct Mol Biol 2004; 11:1060-1067. This article investigates a new signal transduction pathway occurring upon TLR3L stimulation. This pathway, more complex compared with other TLRL pathways, offers additional data regarding the signal transduction pathways of TLRs.
19. Latz E, Schoenemeyer A, Visintin A, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5:190-198.
20. Crozat K, Beutler B. TLR7: a new sensor of viral infection. Proc Natl Acad Sci USA 2004; 101:6835-6836.
21. Hasan U, Chaffois C, Gaillard C, et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174:2942-2950.
22. Zhang D, Zhang G, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:1481-1482. In this article, mammalian TLR11 has been characterized and analysed at the functional level, providing the evidence that the characterization of novel TLRs is still open. Additional human TLRs might therefore be discovered in the future.
23. Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the toll signalling pathway. Nat Immunol 2001; 2:835-841.
24. Serbina NV, Kuziel W, Flavell R, et al. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003; 19:891-901.
25. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIP in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301:640-643.
26. Gil J, Garcia MA, Gomez-Puertas P, et al. TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol 2004; 24:4502-4512.
27. Johnson AC, Heinzel FP, Diaconu E, et al. Activation of Toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci 2005; 46: 589-595. In this study, the possibility of an IFN-γ-independent activation of TLR-4 is investigated and discussed.
28. Lee JY, Ye J, Gao Z, et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003; 278:37041-37051.
29. Hoebe K, Janssen EM, Kim SO, et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4:1223-1229.
30. Diebold SS, Montoya M, Linger H, et al. Viral infection switches non-plasmacytoid dendritic cells into high Interferon producers. Nature 2003; 424:324-328.
31. Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signalling (SOCS) proteins indirectly regulate Toll-like receptor signalling in innate immune cells. J Biol Chem 2004; 279:54708-54715.
32. Rehli M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 2002; 23:375-378.
33. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-4537.
34. Pinhal-Enfield G, Ramanathan M, Hasko G, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. Am J Pathol 2003; 163:711-721.
35. Ojaniemi M, Glumoff V, Harju K, et al. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003; 33:597-605.
36. Bourke E, Bosisio D, Golay J, et al. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003; 102:956-963.
37. Sabroe I, Jones EC, Usher LR, et al. Toll-like receptor (TLR) 2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168:4701-4710.
38. Sabroe I, Prince LR, Jones EC, et al. Selective roles for toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003; 170:5268-5275.
39. Sabroe I, Jones EC, Whyte MKB, Dower SK. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology 2005; 115:90-98.
40. Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol 2004; 16:23-26.
41. Dabbagh K, Lewis DB. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 2003; 16:199-204.
42. Mazzoni A, Segal DM. Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 2004; 75:721-730.
43. Redecke V, Hacker H, Datta SK, et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743.
44. Song PI, Abraham TA, Park Y, et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci 2001; 42:2867-2877.
45. Ikeda T, Funaba M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 2003; 88:21-26.
46. Nagase H, Okugawa S, Ota Y, et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 2003; 171:3977-3982.
47. McCurdy JD, Lin TJ, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 2001; 70:977-984.
48. Varadaradjalou S, Feger F, Thieblemont N, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003; 33:899-906.
49. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
50. Kulka M, Alexopoulou L, Flavell RA, et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004; 114:174-182.
51. Cognasse F, Hamzeh H, Chavarin P, et al. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005; 83:196-198.
52. Kurmar MV, Nagineni CN, Chin MS, et al. Innate immunity in the retina: Toll-like receptor (TLR) signalling in human retinal pigment epithelial cells. J Neuroimmunol 2004; 153:7-15. This review provides pros: con evidence regarding the hygiene hypothesis and the controversial contribution of TLRs in experimental and human asthma.
53. Magone MT, Chan CC, Back L, et al. Systemic or mucosal administration immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur J Immunol 2000; 30:1841-1850.
54. Miyazaki D, Liu G, Clark L, Ono SJ. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Vis Sci 2000; 41:3850-3855.
55. Percopo CM, Hooks JJ, Shinohara T, et al. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol 1990; 145:4101-4107.
56. Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci 2004; 45: 1871-1878.
57. Bielory L. Ocular allergy and dry eye syndrome. Curr Opin Allergy Clin Immunol 2004; 4:421-424.
58. Stahl JL, Barney NP. Ocular allergic disease. Curr Opin Allergy Clin Immunol 2004; 4:456-459.
59. Ueta M, Nochi T, Jang MH, et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 2004; 173:3337-3347.
60. Zhang J, Xu K, Ambati B, Yu FS. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci 2003; 44:4247-4254.
61. Kumagai N, Fukuda K, Fujitsu Y, et al. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 2005; 46:114-120.
62. Bonini S, Micera A, Iovieno A, et al. Expression of Toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 2005; E-pub ahead of print 12 July 2005. This study shows that conjunctival biopsies from VKC patients exhibited significantly enhanced TLR-4 levels and reduced levels of TLR-9 with respect to healthy patients. The authors highlight that the decreased expression of TLR-9 in the epithelium of VKC conjunctiva may represent a key result of the local T helper type 2 driven condition.
63. Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol 2000; 12:35-43.
64. Lawton JA, Ghosh P. Novel therapeutic strategies based on toll-like receptor signaling. Curr Opin Chem Biol 2003; 7:446-451.